Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FKZGF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
XNW-27011
|
|||||
| Synonyms |
XNW 27011; XNW-27011; XNW27011
Click to Show/Hide
|
|||||
| Organization |
Suzhou Sinovent Pharmaceuticals Co.,Ltd.; Shanghai Sinovent Biopharmaceutical Co., Ltd
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 8 Indication(s)
Biliary tract cancer [ICD11:2C15]
Phase 2
Colon cancer [ICD11:2B90]
Phase 2
Esophageal cancer [ICD11:2B70]
Phase 2
Gastric cancer [ICD11:2B72]
Phase 2
Lung cancer [ICD11:2C25]
Phase 2
Ovarian cancer [ICD11:2C73]
Phase 2
Pancreatic ductal adenocarcinoma [ICD11:2C10]
Phase 2
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Claudin-18.2 (CLDN18.2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.